Abviva and Mammastatin Serum Assay (MSA)

Here is an article that speaks about Abviva. The original article I found was by Business Wire and posted on March 24, 2008.

Excerpted from that article:

"Abviva, Inc. (OTCBB: AVVA) today announced the Company launched its new website at www.abviva.com as part of the continued development of its breast cancer diagnostic business and the Mammastatin Serum Assay."

"Abviva’s website is intended to be an informational resource for women and physicians to increase awareness and understanding of the benefits of early breast cancer detection and of the Mammastatin Serum Assay (MSA). In clinical studies, 98% of women with no history of breast cancer had normal or high levels of mammastatin in their MSA blood test. More importantly, 74% of women with a history of breast cancer had no mammastatin present or very low levels. These findings highlight the early detection benefits of the MSA."

"The MSA test can be valuable for early detection of asymptomatic, undiagnosed women. Additionally, more women can have increased access to breast cancer screening with the MSA, especially in underserved areas and populations, because it is a simple blood test. The Company intends to offer the MSA test later this year."

There was a link for more information, so I clicked it. It took me to here. With a little more information than the first article, it also contained a form that I could fill out requesting even more information on the test/ Abviva.

I filled out the form (we'll see what information finds it's way into my in-box...) and when I hit the send button, I ended up at the Abviva website.

Here is the information and link to the second article and the form. An excerpt from that article is below.

"Abviva intends to offer early access to the Mammastatin Serum Assay to women and their physicians, clinics and hospitals later this year."

"The Mammastatin Serum Assay was developed from the Mammastatin technology discovered by scientists at the University of Michigan Cancer Center and originally published in the journal Science. "

For more information, go to the Abviva website.
http://www.abviva.com/BCT.html

Excerpted from the Abviva website:

"The Mammastatin Serum Assay (MSA) is a biological measure of breast cancer risk. It is a non-invasive method of detecting the level of the protein Mammastatin in blood serum. The MSA has been studied as a means to provide early detection of individuals with breast cancer who are undiagnosed and to identify individuals who are at increased risk of developing breast cancer, before cancer develops and can be diagnosed by conventional means."

"We will provide you with up-to-date information on Abviva, including our press releases, a press kit you can download, and a glossary of terms for your use."

For Additional Information Please Contact:
Ms. Adina Shaheri
Phone: 310-443-4102
Email: Adina@abviva.com

For moreinformation on the Mammastatin Serum Assay (MSA) please visit: www.breastcancerdiagnostic.com

(This is the same web address for the article and form I mentioned above.)